Coronaviruses
A significant shift in the treatment of patients with "surgical" coronary artery disease (CAD) occurred during the COVID-19 pandemic in the United Kingdom. Investigators enrolled 215 patients in the prospective UK-ReVasc Registry (ReVR) who underwent percutaneous coronary intervention (PCI) between March 1, 2020, and July 31, 2020, to
Coronaviruses
The COVID-19 pandemic has brought significant changes to the management and treatment of pediatric appendicitis. Historically, appendicitis has been treated with surgery, but the pandemic has led to a decrease in incidence, making it challenging for pediatric care providers to diagnose and treat the condition. Many patients are now presenting
COVID-19
Polio, an infectious disease that was largely eradicated in Canada nearly three decades ago, has re-emerged in some western nations, sparking concerns about a potential outbreak in Canada. Despite widely available and effective vaccines against the illness, disruptions from the COVID-19 pandemic and vaccine hesitancy have left some Canadians vulnerable
COVID-19
As the world grapples with the devastating consequences of climate change, Far Eastern New Century (FENC) is taking bold steps to reduce its carbon footprint and promote sustainable practices. The company's 9th edition of the Sustainable Report highlights its commitment to empowering possibilities and confronting challenges with corporate
Coronaviruses
Research from Nanjing Forestry University and colleagues reveals that China's strict control measures during the COVID-19 pandemic led to significant reductions in carbon dioxide emissions. The study, which utilized atmospheric CO observations and the WRF-STILT atmospheric transport model, found that emissions decreased by 37.1-40.2% in Nanchang
Coronaviruses
Russia's invasion of Ukraine has put the 50-year-old Nuclear Nonproliferation Treaty under unprecedented stress, with experts warning that the world is closer than ever to a potential nuclear conflict. The U.N.-sponsored conference, delayed by the pandemic, is set to begin on Monday with representatives from over
COVID-19
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for Gilead Sciences' remdesivir, marketed as VEKLURY, for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients. The revocation, effective April 25, 2022, was made possible by the approval of a supplemental
COVID-19
Senate Democrats are poised to propose $21 billion in new emergency funds to combat the coronavirus and prepare for emerging outbreaks, including the possibility of monkeypox. The proposal, championed by Sen. Patrick J. Leahy, sets aside $16 billion for the Department of Health and Human Services to fight the coronavirus
Coronaviruses
Research has shown that Artificial Intelligence (AI) is being utilized in various aspects of COVID-19 pandemic management, including rapid disease detection, accurate prediction of epidemic patterns, forecasting disease and psychological impact, and prediction of drug-protein interactions for repurposing drugs. The Indian Statistical Institute has been at the forefront of this
Coronaviruses
New research reveals significant differences in symptomatic presentation of children infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) between the third and fourth waves of the pandemic in Israel. The findings, published in the European Journal of Pediatrics, highlight the varying impact of different variants on children's health.
Coronaviruses
Research on the Coronavirus pandemic continues to uncover new insights into the behavior of the virus and its impact on global health. A recent study, published in the journal Biophysics, has utilized data-driven epidemiological parameters to develop a mathematical model that predicts the spread of COVID-19 in India. The study,
Epidemics
The World Health Organization (WHO) has released a report highlighting the need for increased vaccine development and improved access to existing vaccines to combat antimicrobial-resistant (AMR) bacteria. The report identifies 61 vaccine candidates, but notes that only one of the top six bacterial pathogens responsible for deaths due to AMR
